Cognitive Disturbance
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Effects of IV-Administered Ca-DTPA and Zn-DTPA To Treat Patients With Gadolinium Deposition Disease (NCT02947022) | University of North Carolina, Chapel Hill | 2016-10-01 |
Track Cognitive Disturbance automatically
Every clearance here is in the API, with alerts when new ones post.